久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

德國AyoxxA  
Ayoxxa是新加坡國立大學的衍生公司，生產從一滴血同時驗出和測量作為疾病指標的多種蛋白質。這家獲得基金會資助的公司去年在奧地利的一項全球生命科學商業計劃比賽中贏得冠軍。
 
AyoxxA, an international biotech company based in Cologne, Germany, and Singapore, has developed a proprietary technology platform for multiplexed protein analysis. Core to this cutting-edge technology are “In-situ Encoded Bead-based Arrays” (IEBA) which allow simultaneous, precise and cost effective protein analysis in very small sample volumes.

These novel biochips allow users to combine high throughput screening and multiplexed assay formats at the same time and thus have the potential to revolutionize applications in biomedical research, pharmacological screening, and diagnostics.

AyoxxA was founded as a spin-off of the National University of Singapore (NUS) in 2010. The company received multiple grants in Singapore from the National Research Foundation (NRF), the SMART Innovation Centre (Singapore MIT Alliance for Research and Technology), and SPRING's Technology Enterprise Commercialisation Scheme (TECS). It established corporate headquarters in Cologne in Spring 2012 and continues to run operations in Singapore.